Microfluidics can precisely control the physiochemical properties of nanoparticles by mixing to the nanoliter. For this reason, nanoparticles for the transport of peptide drugs are to be developed in the study presented here with the help of chitosan from Heppe Medical Chitosan GmbH.
Next week, the 14th World Meeting on Pharmacy, Biopharmacy and Pharmaceutical Technology (PBP) will take place in Vienna together with ResearchPharm. Alongside university researchers, a large number of companies from the pharmaceutical industry will be represented. We are very excited to be there this year as an exhibitor.
Artificially produced nerve conduits are promising alternatives to autologous nerve grafts in the treatment of damaged nerves. In this study, the physiochemical properties of chitosan/poly-ε-caprolactone nerve conduits will be improved by using the chitosan crosslinker genipin.
The use of microgels is one way of biomimetically mimicking tissue. In the presented study, chitosan microgels will be functionalized with Zn (II) and Cu (II) ions to improve their physicochemical properties.
At EUCHIS 2023, HMC is launching chitosan standards for the first time. ,,We are proud to finally offer a reliable standard for molecular weight analysis'', says Katja Richter, Managing Director of Heppe Medical Chitosan. This means that researchers and customers no longer need to compare chitosans with other substances such as pullulan or PEG/PEO for molecular weight analysis. Now reliable chitosans can be used. No approximations. No thinking about whether they are the right, reliable results. Reliable chitosans for excellent research and outstanding pharmaceutical products.
After traveling the beautiful landscape of Iceland, our Chitosan crab is now on its way to Siglufjörður for EUCHIS 2023. We are very much looking forward to seeing everyone again and are excited about the scientific exchange. Besides Chitosan and our crab, we have great news in our luggage. Stay tuned!
Chitosan bioglass networks can be used as biomaterials in medicine, for example, as bone implants. Their physiochemical and mechanical properties can be improved by crosslinkers and various stabilization methods. In the presented study, six of them were compared with each other.
We are very pleased to announce that Katja Richter, CEO of Heppe Medical Chitosan GmbH, has been appointed to the scientific committee of EUCHIS 2023. EUCHIS 2023, the International Conference of the European Chitin Society (EUCHIS 2023) and the 15th International Conference on Chitin and Chitosan (15th ICCC) will be held in Siglufjörður, Iceland, from September 11-14, 2023.
In 2019, many interesting and innovative research articles about chitosan and chitosan derivatives were published. In this article we present you an overview which chitosan reserach topics were important in 2019.
Worldwide, our chitosan and chitosan derivatives are used in research. We created a list of scientific articles published in 2018 using chitosan from HMC. Nanoparticles from chitosan or chitosan derivatives were most frequently produced and tested for a wide variety of applications, mainly directed drug delivery and tissue engineering. Curious where to find chitosan by HMC in research?
